{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 1-[3-(2-Aminoethyl)-1''H''-indol-5-yl]ethanone
| image = Acetryptine.svg
| width = 200px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 3551-18-6
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 20810
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 19586
| UNII = N9VWZ34G5E
| KEGG = 
| ChEBI = 
| ChEMBL = 110317

<!--Chemical data-->
| C=12 | H=14 | N=2 | O=1
| molecular_weight = 202.257 g/mol
| SMILES = CC(=O)C1=CC2=C(C=C1)NC=C2CCN
| StdInChI_Ref = 
| StdInChI = 1S/C12H14N2O/c1-8(15)9-2-3-12-11(6-9)10(4-5-13)7-14-12/h2-3,6-7,14H,4-5,13H2,1H3
| StdInChIKey_Ref = 
| StdInChIKey = RAUGYAOLAMRLLZ-UHFFFAOYSA-N
| synonyms = W-2965-A; 5-Acetyltryptamine; 5-Acetyl-3-(2-aminoethyl)indole; 
}}

'''Acetryptine''' ([[International Nonproprietary Name|INN]]) (developmental code name '''W-2965-A'''), also known as '''5-acetyltryptamine''' ('''5-AT'''),<ref name="pmid13953098">{{cite journal | vauthors = HARTIGAN JM, PHILLIPS GE | title = Tissue distribution and metabolism of 5-acetyltryptamine in the mouse | journal = Biochem. Pharmacol. | volume = 12 | issue = | pages = 585–8 | year = 1963 | pmid = 13953098 | doi = | url = }}</ref> is a [[drug]] described as an [[antihypertensive agent]] which was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA6|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=6–}}</ref> Structurally, acetryptine is a [[substituted tryptamine]], and is closely related to other substituted tryptamines like [[serotonin]] (5-hydroxytryptamine).<ref name="Elks2014" /> It was developed in the early 1960s.<ref name="Elks2014" /><ref name="pmid13953098" /> The [[receptor binding|binding]] of acetryptine to [[serotonin receptor]]s does not seem to have been well-investigated, although it was assessed at the [[5-HT1A receptor|5-HT<sub>1A</sub>]] and [[5-HT1D receptor|5-HT<sub>1D</sub> receptor]]s and found to bind to them with high [[affinity (pharmacology)|affinity]].<ref name="pmid8568822">{{cite journal | vauthors = Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhi S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C | title = Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors | journal = J. Med. Chem. | volume = 39 | issue = 1 | pages = 314–22 | year = 1996 | pmid = 8568822 | doi = 10.1021/jm950498t | url = }}</ref> The drug may also act as a [[monoamine oxidase inhibitor]] (MAOI); specifically, as an [[enzyme inhibitor|inhibitor]] of [[MAO-A]].<ref name="pmid11002183">{{cite journal | vauthors = Veselovsky AV, Medvedev AE, Tikhonova OV, Skvortsov VS, Ivanov AS | title = Modeling of substrate-binding region of the active site of monoamine oxidase A | journal = Biochemistry Mosc. | volume = 65 | issue = 8 | pages = 910–6 | year = 2000 | pmid = 11002183 | doi = | url = }}</ref><ref name="pmid12570845">{{cite journal | vauthors = Ramsay RR, Gravestock MB | title = Monoamine oxidases: to inhibit or not to inhibit | journal = Mini Rev Med Chem | volume = 3 | issue = 2 | pages = 129–36 | year = 2003 | pmid = 12570845 | doi = | url = }}</ref>

==See also==
{{Colbegin|2}}
* [[5-Benzyloxytryptamine]]
* [[5-Carboxamidotryptamine]]
* [[5-Ethoxy-DMT]]
* [[5-Methoxytryptamine]]
* [[5-(Nonyloxy)tryptamine]]
* [[Azepindole]]
* [[Indorenate]]
* [[Metralindole]]
* [[Pargyline]]
* [[Pirlindole]]
* [[Sumatriptan]]
* [[Tetrindole]]
{{Colend}}

==References==
{{reflist|30em}}

{{Serotonin receptor modulators}}
{{Tryptamines}}

[[Category:Antihypertensive agents]]
[[Category:Serotonin receptor agonists]]
[[Category:Tryptamines]]


{{antihypertensive-stub}}